127 related articles for article (PubMed ID: 15811140)
1. Diazoxide-mediated insulin suppression in obese men: a dose-response study.
Schreuder T; Karreman M; Rennings A; Ruinemans-Koerts J; Jansen M; de Boer H
Diabetes Obes Metab; 2005 May; 7(3):239-45. PubMed ID: 15811140
[TBL] [Abstract][Full Text] [Related]
2. Weight loss in obese men by caloric restriction and high-dose diazoxide-mediated insulin suppression.
van Boekel G; Loves S; van Sorge A; Ruinemans-Koerts J; Rijnders T; de Boer H
Diabetes Obes Metab; 2008 Dec; 10(12):1195-203. PubMed ID: 18476985
[TBL] [Abstract][Full Text] [Related]
3. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.
Hung YJ; Chen YC; Pei D; Kuo SW; Hsieh CH; Wu LY; He CT; Lee CH; Fan SC; Sheu WH
Diabet Med; 2005 Aug; 22(8):1024-30. PubMed ID: 16026368
[TBL] [Abstract][Full Text] [Related]
4. High-Dose, Diazoxide-Mediated Insulin Suppression Boosts Weight Loss Induced by Lifestyle Intervention.
Loves S; van Groningen L; Filius M; Mekking M; Brandon T; Tack CJ; Hermus A; de Boer H
J Clin Endocrinol Metab; 2018 Nov; 103(11):4014-4022. PubMed ID: 30202851
[TBL] [Abstract][Full Text] [Related]
5. Effects of Diazoxide-Mediated Insulin Suppression on Glucose and Lipid Metabolism in Nondiabetic Obese Men.
Loves S; van Groningen L; Filius M; Mekking M; Brandon T; Tack CJ; Hermus A; de Boer H
J Clin Endocrinol Metab; 2018 Jun; 103(6):2346-2353. PubMed ID: 29618011
[TBL] [Abstract][Full Text] [Related]
6. Influence of BMI and gender on postprandial hormone responses.
Carroll JF; Kaiser KA; Franks SF; Deere C; Caffrey JL
Obesity (Silver Spring); 2007 Dec; 15(12):2974-83. PubMed ID: 18198306
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of orlistat on postprandial serum leptin levels in nondiabetic obese patients.
Sahin M; Tanaci N; Yucel M; Kutlu M; Tutuncu NB; Pamuk B; Guvener ND
Minerva Endocrinol; 2008 Sep; 33(3):169-73. PubMed ID: 18846024
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men.
Nagpal J; Pande JN; Bhartia A
Diabet Med; 2009 Jan; 26(1):19-27. PubMed ID: 19125756
[TBL] [Abstract][Full Text] [Related]
11. Improvement of insulin resistance after diet with a whole-grain based dietary product: results of a randomized, controlled cross-over study in obese subjects with elevated fasting blood glucose.
Rave K; Roggen K; Dellweg S; Heise T; tom Dieck H
Br J Nutr; 2007 Nov; 98(5):929-36. PubMed ID: 17562226
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
13. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
Albert SG; Haas MJ; Mooradian AD
Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
[TBL] [Abstract][Full Text] [Related]
14. Meal suppression of circulating ghrelin is normalized in obese individuals following gastric bypass surgery.
Engström BE; Ohrvall M; Sundbom M; Lind L; Karlsson FA
Int J Obes (Lond); 2007 Mar; 31(3):476-80. PubMed ID: 16924271
[TBL] [Abstract][Full Text] [Related]
15. Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study.
Wang TF; Pei D; Li JC; Tsai WC; Tsai CC; Yao CY; Chang ET; Hsieh MC; Su KY; Kuo SW
Int J Clin Pract; 2005 Jul; 59(7):746-50. PubMed ID: 15963197
[TBL] [Abstract][Full Text] [Related]
16. Effect of an acute hyperinsulinaemic clamp on post-prandial lipaemia in subjects with insulin resistance.
Allister EM; James AP; Watts GF; Barrett PH; Mamo JC
Eur J Clin Invest; 2006 Jul; 36(7):489-96. PubMed ID: 16796606
[TBL] [Abstract][Full Text] [Related]
17. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
18. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
Kopelman P; Bryson A; Hickling R; Rissanen A; Rossner S; Toubro S; Valensi P
Int J Obes (Lond); 2007 Mar; 31(3):494-9. PubMed ID: 16953261
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
[TBL] [Abstract][Full Text] [Related]
20. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions.
Cremonini F; Camilleri M; Vazquez Roque M; McKinzie S; Burton D; Baxter K; Zinsmeister AR
Gastroenterology; 2006 Nov; 131(5):1431-9. PubMed ID: 17101319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
